manejo de hiperglicemia en hospitalizados.pptx

RafaelLopez182911 1 views 41 slides Sep 30, 2025
Slide 1
Slide 1 of 41
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41

About This Presentation

HIPERGLICEMIA


Slide Content

MANEJO DE HIPERGLUCEMIA EN PACIENTES HOSPITALIZADOS R2 MEDICINA INTERNA RAFAEL LOPEZ VARGAS

15 14 12 w õ 11 10 Distribution Glucose Values í the National Heart Care Patient Cohort 50 100 150 200 250 300 350 400 450 500 550 600 Admission Glucose (mg/dL) Kosiborod M et al. Circulation. 2009;119:1899- 1907

CUAL DEBE SER EL MANEJO DE UN PACIENTE CON DIABETES MELLITUS TIPO 2 DURANTE UNA HOSPITALIZACIÓN POR OTRA CAUSA ?

Basal/bolo 130 Pocientes insulins Dias de hospi alización Deas de hospi alización 5.2 dna

AO 18 160 140 100 7 8 Days of Therapy Ftgnre I—Changes in blo nd glucose conrcntrntions in yatietits treated with glargine plus gfu- lisinc and with SSI . *P 0.0J ; TP < 0.d5. 10

> ae recomienoo ia uriiizocion oe esouetnas oasøu QUE ES DIAGNOSTICADO CON DM 2 DURANTE UNA HOSPITALIZACION FOR OTRA CAUSA*

BOLUS + CORRECTION

141 - 180 1B1 - 220 221 - 260 10 261 - 300 10 12 301 - 350 10 12 351 - 400 12 16 >40O zs ïa

Cl i n i c a I C a r e / E d u c a I i o n / N u I r i I i a n /P s y c h a s a c i a I R e s e a z < h Basal- Belus W!t h a Basal Plus Correction Znsul!n Rep!nsen fer ¢he Hosp!tml Manapemen0 ef Me4!caI an4 Surp!cal !a& Patients W!eh Basal Plu s Txial D*zwSxiw,wo' Cozoronire Nxmou, no' critically ill patients have reported that improvement of glycemñ control reduces hospital complications ( I, hospital stay, and mo oality (6— 8). In patients with T2D admit red to general medicine and surgery services, tecent Tdndoniized, controlled trials Ave shown that treat- ment with a heal- bolus regimen results

160 220 100 T80 160 140 Random- Breakfast VBasal Bolus OBasal Plus g ; Day of Treatment Lunch OBasal Plus Dinner Time of Day Bedtime

N H 12— 20 hours detemir - 6- 23 hours (dose dependant) glargine - 20- 26 hours Hours Note: action cuves axe approxi ations for illus rative pu poses. Ac ua patient 15 18 17 18 19 20 21 esponse will vas.

200 180 160 140 120

de hipoglucemio, fueron Simïlores en los 2 grupos: VO NPH + Regular = Detemir + Asport

141 - 180 1B1 - 220 221 - 260 10 261 - 300 10 12 301 - 350 10 12 351 - 400 12 16 >40O zs ïa

reducimos dosis de insulins basal un 10a - 20%

Omitir medicociones oroles o inyectobles diferentes a la insulins Administror la mitod de la dosis usual de NPH o un 70% del Si el pociente utilize insulins premezclodo odministror la

RABBIT TRIAL Glargine + Glulisine N= 104 Half as glargine once daily Half as glulisine before meals 211 PACIENTES CON DIABETES TIPO 2 SOMETIDOS A CIRUGIA GENERAL RANDOMIZACION Sliding scale insulin SSRI) N= 107 Group 2: 4 times/day for BG x14O mg/dl

220 180 140 120 B 220 200 180 160 140 120 Duration of Treatment (days) Lunch Breakfast Umpierrez G E et al. Dinner t ) Bedtime

c plic ciones intrahospiłalorios
Tags